Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With AD, PSP, and CBS

This parallel-design, double-blind randomized clinical trial assesses the safety, tolerability, and pharmacodynamics of the microtubule stabilizer TPI-287 in patients with Alzheimer disease or the 4-repeat tauopathies progressive supranuclear palsy and corticobasal syndrome.
Source: JAMA Neurology - Category: Neurology Source Type: research